Hope is to develop targeted treatments for affected patients Since the beginning of the COVID-19 pandemic, researchers and doctors alike have agreed that as a person’s age progresses, so does the danger of the virus to their recovery and ultimate survival. But one question…
Your Coronavirus Update for November 18; stay up to date with Elite. More than 54.8 million cases of coronavirus (COVID-19) have been diagnosed worldwide as of Monday evening, including at least 1.32 million deaths. Healthcare officials in the United States have reported more than…
“Unexplained Illness’ in one patient leads to halt On Monday, Johnson & Johnson announced they would be temporarily pausing dosing in all COVID-19 vaccine trials, including their Phase III ENSEMBLE trial, due to an unexplained illness in a participant. Adverse events – illnesses, accidents,…
Introduction Being an adult carries certain rights and responsibilities. We are expected to manage our lives with an amount of panache as healthcare providers, understanding that how we exist as individuals may be modeled by others in our community. The decisions we make are…
New evidence put forth at AAIC that vaacines might lower risk of Alzheimer’s For years, public health officials have been trying to dispel the myth that people who get a flu shot are more likely to get Alzheimer’s disease. Now those officials are armed…
AstraZeneca works to make Oxford vaccine available ASAP AstraZeneca (AZ) is advancing its response to address the unprecedented challenges of COVID-19, collaborating with numerous countries and organizations to make the University of Oxford’s vaccine widely accessible around the world in an equitable manner. AZ has…
Anakinra shows breathing improvements, but further study necessary A drug traditionally used in the treatment of arthritis, anakinra, may possess benefits in the treatment of severely ill COVID-19 patients, according to a new Italian study. Researchers found more than 70 percent of seriously ill…
A breakthrough treatment to help children fight against allergens comes just as COVID-19 creates new “challenges” for this patient population. For patients who live with chronic food allergies, the positives of social distancing may be subsequently resulting in a dangerous dynamic of social distractions…